Emany Sravan Kumar
- SEC CIK
- 0001897662
In the past year, 1 open-market sale filing worth $170.6K and no purchases.
Current role at each company
- ASRT Assertio Holdings, Inc.Directoras of Jun 16, 2026
- BEAM Beam Therapeutics Inc.Chief Financial Officeras of Apr 2, 2026
- KYTX Kyverna Therapeutics, Inc.Directoras of Feb 26, 2026
- IRWD Ironwood Pharmaceuticals IncSVP, COO and CFOas of Nov 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $170.6K
- 1 filing
- Net
- −$170.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Emany Sravan Kumar as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BEAM Beam Therapeutics Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 (view filing) | Dec 31, 2025 | 5 days | Emany Sravan KumarChief Financial Officer | SSale | −6.29K | $27.10 | −$170.6K | −7.9%73.7K after | 10b5-1 |
IRWD Ironwood Pharmaceuticals Inc
SVP, COO and CFO4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2024 (view filing) | Nov 18 | 2 days | Emany Sravan KumarSVP, COO and CFO | SSaleClass A Common Stock | −11.0K | $4.08 | −$44.9K | −3.4%309.6K after | |
| Mar 6, 2024 (view filing) | Mar 4 | 2 days | Emany Sravan KumarSVP, Chief Financial Officer | PPurchaseClass A Common Stock | +10.7K | $9.38 | +$100.2K | +3.7%301.7K after | |
| Sep 18, 2023 (view filing) | Sep 15 | 3 days | Emany Sravan KumarSVP, Chief Financial Officer | PPurchaseClass A Common Stock | +36.1K | $8.32 | +$300.1K | +23.6%188.7K after | |
| Nov 23, 2022 (view filing) | Nov 21 | 2 days | Emany Sravan KumarSVP, Chief Financial Officer | SSaleClass A Common Stock | −6.58K | $11.56 | −$76.0K | −7.7%78.4K after |